Compounds > thiorphan
Page last updated: 2024-10-26

thiorphan and Diabetic Retinopathy

thiorphan has been researched along with Diabetic Retinopathy in 1 studies

Thiorphan: A potent inhibitor of membrane metalloendopeptidase (ENKEPHALINASE). Thiorphan potentiates morphine-induced ANALGESIA and attenuates naloxone-precipitated withdrawal symptoms.

Diabetic Retinopathy: Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Prasad, T1
Roksnoer, LC1
Zhu, P1
Verma, A1
Li, Y1
Batenburg, WW1
de Vries, R1
Danser, AH1
Li, Q1

Other Studies

1 other study available for thiorphan and Diabetic Retinopathy

ArticleYear
Beneficial Effects of Combined AT1 Receptor/Neprilysin Inhibition (ARNI) Versus AT1 Receptor Blockade Alone in the Diabetic Eye.
    Investigative ophthalmology & visual science, 2016, 12-01, Volume: 57, Issue:15

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Biphenyl Compounds; Blotting, Western; Diabetes Me

2016